Peter Brown
University of Oxford · H:S Rigshospitalet, Department of Hematology, Denmark · Cephalon
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Peter Brown as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:27 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04080674 · Using DBS to Probe Basal Ganglia DysfunctionUniversity of Oxford · unknown · Parkinson's Disease, Tremor, Dystonia · principal investigator
- N/ANCT04047498 · Alternating DBS for Stepping Control in Parkinson's DiseaseUniversity of Oxford · unknown · Parkinson Disease · principal investigator
- Ph2NCT00865969 · Belinostat in Relapsed or Refractory Peripheral T-Cell LymphomaSpectrum Pharmaceuticals, Inc · completed · Peripheral T-cell Lymphoma · principal investigator
- Ph2NCT00242827 · Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple MyelomaCephalon · terminated · Myeloma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.